Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol. (2020)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2019-033009

PubMed Identifier: 32184305

Publication URI: http://europepmc.org/abstract/MED/32184305

Type: Journal Article/Review

Volume: 10

Parent Publication: BMJ open

Issue: 3

ISSN: 2044-6055